Groove vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Groove

ChallengerSales & Revenue

Sales Engagement & Salesforce Automation

Salesforce-native sales engagement platform acquired by Clari in 2023. 4,700+ G2 reviews at 4.7/5. Sequences, email tracking, and activity sync built natively inside Salesforce for enterprise teams.

About

Groove is a Salesforce-native sales engagement platform founded in 2014 and acquired by Clari in August 2023. Operating as Groove by Clari, the platform provides email and calendar automation, multi-step sales sequences, meeting scheduling, and real-time Salesforce activity sync—all built to work natively within Salesforce without data synchronization complexity. Groove has accumulated over 4,700 G2 reviews at a 4.7/5 rating, reflecting strong enterprise user satisfaction.\n\nGroove's Salesforce-native architecture eliminates the sync issues that plague third-party sales engagement tools, writing all activity data directly to Salesforce objects rather than a separate data layer. This makes Groove particularly attractive to enterprise sales organizations that require audit trails, RevOps reporting accuracy, and tight CRM governance. The platform supports multi-step email sequences, phone tasks, LinkedIn steps, and account-based plays, with AI features that surface recommended actions and flag at-risk deals.\n\nFollowing Clari's December 2025 merger with Salesloft, the combined entity now offers overlapping capabilities in sales engagement (Groove and Salesloft Cadence) and conversation intelligence (Clari Copilot and Salesloft Conversations). This consolidation positions the merged company as an end-to-end autonomous revenue platform spanning engagement, forecasting, and pipeline management. Groove remains the preferred choice for enterprises deeply embedded in Salesforce that prioritize native integration over broader platform features.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.